Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 1 |
2022 | 1 |
2023 | 3 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells.
J Neurooncol. 2023 May;163(1):143-158. doi: 10.1007/s11060-023-04319-1. Epub 2023 May 15.
J Neurooncol. 2023.
PMID: 37183219
Free PMC article.
The first-in-class ERK inhibitor ulixertinib shows promising activity in mitogen-activated protein kinase (MAPK)-driven pediatric low-grade glioma models.
Sigaud R, Rösch L, Gatzweiler C, Benzel J, von Soosten L, Peterziel H, Selt F, Najafi S, Ayhan S, Gerloff XF, Hofmann N, Büdenbender I, Schmitt L, Foerster KI, Burhenne J, Haefeli WE, Korshunov A, Sahm F, van Tilburg CM, Jones DTW, Pfister SM, Knoerzer D, Kreider BL, Sauter M, Pajtler KW, Zuckermann M, Oehme I, Witt O, Milde T.
Sigaud R, et al. Among authors: gatzweiler c.
Neuro Oncol. 2023 Mar 14;25(3):566-579. doi: 10.1093/neuonc/noac183.
Neuro Oncol. 2023.
PMID: 35882450
Free PMC article.
Item in Clipboard
Functional Therapeutic Target Validation Using Pediatric Zebrafish Xenograft Models.
Gatzweiler C, Ridinger J, Herter S, Gerloff XF, ElHarouni D, Berker Y, Imle R, Schmitt L, Kreth S, Stainczyk S, Ayhan S, Najafi S, Krunic D, Frese K, Meder B, Reuss D, Fiesel P, Schramm K, Blattner-Johnson M, Jones DTW, Banito A, Westermann F, Oppermann S, Milde T, Peterziel H, Witt O, Oehme I.
Gatzweiler C, et al.
Cancers (Basel). 2022 Feb 8;14(3):849. doi: 10.3390/cancers14030849.
Cancers (Basel). 2022.
PMID: 35159116
Free PMC article.
Item in Clipboard
Evaluation of Antitumor and On-Target Activity of HDAC Inhibitors with the Zebrafish Embryo Xenograft Model.
Gatzweiler C, Ridinger J, Ayhan S, Najafi S, Peterziel H, Witt O, Oehme I.
Gatzweiler C, et al.
Methods Mol Biol. 2023;2589:75-85. doi: 10.1007/978-1-0716-2788-4_5.
Methods Mol Biol. 2023.
PMID: 36255618
Item in Clipboard
Combining APR-246 and HDAC-Inhibitors: A Novel Targeted Treatment Option for Neuroblastoma.
Müller M, Rösch L, Najafi S, Gatzweiler C, Ridinger J, Gerloff XF, Jones DTW, Baßler J, Kreth S, Stainczyk S, Frese K, Meder B, Westermann F, Milde T, Peterziel H, Witt O, Oehme I.
Müller M, et al. Among authors: gatzweiler c.
Cancers (Basel). 2021 Sep 5;13(17):4476. doi: 10.3390/cancers13174476.
Cancers (Basel). 2021.
PMID: 34503286
Free PMC article.
Item in Clipboard
Rapid In Vivo Validation of HDAC Inhibitor-Based Treatments in Neuroblastoma Zebrafish Xenografts.
Wrobel JK, Najafi S, Ayhan S, Gatzweiler C, Krunic D, Ridinger J, Milde T, Westermann F, Peterziel H, Meder B, Distel M, Witt O, Oehme I.
Wrobel JK, et al. Among authors: gatzweiler c.
Pharmaceuticals (Basel). 2020 Oct 27;13(11):345. doi: 10.3390/ph13110345.
Pharmaceuticals (Basel). 2020.
PMID: 33121173
Free PMC article.
Item in Clipboard
Cite
Cite